Since the expression of the Gal-8 gene LGALS8 is much more amplified in a variety of tumours compared with Gal-1 and Gal-3, possibly its most important function remains its role in cancer6, particularly in angiogenesis and lymphangiogenesis, and inhibiting these processes by a Gal-8 inhibitor seems a plausible therapeutic option7. Here, LGALS8 is linked to neoplasm.